Article
Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?
The Lancet. Oncology - 1 Sept 2009
Achatz Maria Isabel Waddington, Hainaut Pierre, Ashton-Prolla Patricia
Abstract excerpt
The unusually high population frequency of a germline TP53 mutation (R337H) predisposing to early cancer has led to mass newborn testing for this mutation in the State of Paraná, southern Brazil. Newborn screening for inherited cancer risk is complex and controversial. In this paper, we discuss the justifications for this screening by considering the medical and scientific evidence for this mutation. R337H has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
